Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03722017 · ClinicalTrials.gov registry record · NA

Drug Reduction in Older Patients: The DROP Trial

A NA study of Frail Elderly and Geriatric Assessment, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
260
Enrollment target
1
Study location

NCT03722017 is a NA study of Frail Elderly and Geriatric Assessment that has completed, run by VA Office of Research and Development. The registered enrollment target is 260 participants, above the 160-participant average among 8 other Frail Elderly trials with a reported enrollment target (63% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03722017, a NA study of Frail Elderly and Geriatric Assessment, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
260 participants
Enrollment target
1
Study location

Study Summary

Project Objectives: The proposed randomized, controlled trial will evaluate the effects of procedures to reduce medications among hospitalized older Veterans discharged to nursing homes using an hybrid study design to inform future efforts to spread it across VA. Project Background/Rationale: Patients discharged to nursing homes for short stays represent the largest group of Medicare beneficiaries discharged to post-hospital services and are a particularly high risk group for loss of independence and other poor clinical outcomes. This investigative team recently completed a VA-funded Quality Improvement Award and a Centers for Medicare and Medicaid Services (CMS) Innovation Award, both of which provide strong results related to the occurrence of polypharmacy and the relationship between polypharmacy and geriatric syndromes (e.g., medications associated with falls) in this patient population. Based on these data, the investigators developed and pilot-tested a patient-centered deprescribing set of procedures combined with standardized questions for eight geriatric syndromes to be implemented in the hospital and monitored during the nursing home stay. Project Methods: The investigators propose an innovative hybrid study design that will be conducted in one VA hospital. The goal of the proposed DROP intervention is to safely deprescribe medications, as defined by reducing doses or stopping medications, based on a combination of clinical criteria and Veteran preferences. This randomized, controlled trial conducted over three years will evaluate the effects of this hospital-based intervention on medication use, geriatric syndromes, and health status across Veterans' care transitions from the hospital to nursing home to home to include a 90-day follow-up period after leaving the nursing home. The hypothesis is that reducing medications for older Veterans will favorably impact geriatric syndromes. Additionally, the investigators aim to understand Veteran, both VA and non-

Interventions

  • OTHER Deprescribing intervention

Study Locations (1)

Tennessee

  • Tennessee Valley Healthcare System Nashville Campus, Nashville, TN - Nashville

Trial Details

FieldValue
Enrollment Target 260 participants
Start Date 2019-10-07
Est. Completion 2023-03-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT03722017

The ClinicalTrials.gov registry entry for NCT03722017 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 160-participant average among 8 other Frail Elderly trials with a reported enrollment target (63% higher). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Frail Elderly appearing as the primary indexed condition, and to 1 intervention - of which Deprescribing intervention is the first listed.

NCT03722017 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT03722017 about?

NCT03722017 is a clinical study titled "Drug Reduction in Older Patients: The DROP Trial". Project Objectives: The proposed randomized, controlled trial will evaluate the effects of procedures to reduce medications among hospitalized older Veterans discharged to nursing homes using an hybrid study design to inform future efforts to spread it across VA. Project Background/Rationale: Patie...

What is the current status of trial NCT03722017?

This trial is currently completed. It is a NA study. The enrollment target is 260 participants. The study started on 2019-10-07. Estimated completion is 2023-03-31.

What conditions does trial NCT03722017 study?

This clinical trial studies the following conditions: Frail Elderly, Geriatric Assessment, Patient Centered Care, Skilled Nursing Facilities.

What interventions are being tested in trial NCT03722017?

The interventions under investigation include: Deprescribing intervention (OTHER).

Who is sponsoring clinical trial NCT03722017?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03722017 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Frail Elderly

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.